He Lab Awarded NIH R01 Grant

Yiping He, PhD

The lab of Yiping He, PhD was recently awarded an NIH R01 grant titled “Exploiting MTAP Deletion for GBM Therapeutics.”  Studies will be performed to determine the pathological consequences of MTAP deletion in glioblastoma and to take advantage of this genetic alteration for glioblastoma treatments. This grant represents a collaborative effort between the He lab, Dr. Hai Yan, Dr. Roger McLendon, and Dr. Darell Bigner.